Cavalier Investments, LLC Enanta Pharmaceuticals Inc Transaction History

Cavalier Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 03, 2019	SELL	$69.08 - $105.66 $828,960 - $1.27 Million	-12,000 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$65.41 - $84.65 $287,804 - $372,460	4,400 Added 57.89%	12,000 $850,000
Q2 2018 Aug 03, 2018	BUY	$81.85 - $120.51 $139,145 - $204,867	1,700 Added 28.81%	7,600 $880,000
Q1 2018 May 10, 2018	BUY	$57.91 - $92.15 $341,669 - $543,685	5,900 New	5,900 $477,000

108

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Cavalier Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Cavalier Investments, LLC with notifications on news.